1206800-42-1Relevant articles and documents
TRK INHIBITOR AS ANTI-CANCER DRUG
-
Paragraph 0202, (2021/07/17)
The present disclosure relates to a group of tropomyosin receptor kinase inhibitors comprising an amido-phenoxy-indazole structure fragment. These compounds show potent inhibitory effects on various oncogenic kinases, especially TRK, and thus can be used
AMIDOPHENOXYINDAZOLES USEFUL AS INHIBITORS OF C-MET
-
Page/Page column 14, (2010/02/17)
The present invention provides amidophenoxyindazole compounds useful in the treatment of cancer.